个体化连接引导对比常规靶向加速θ爆发刺激治疗抑郁的随机双盲平行试验
该单中心随机双盲三臂试验纳入123例重度抑郁或双相II型抑郁成人,比较5-cm规则、结构连接引导和功能连接引导的iTBS靶向。结构连接引导iTBS在第2周HAM-D减分显著优于5-cm规则,第6周两种连接引导均优于5-cm规则,但第12周组间差异不再显著,不良事件相当。
要点
- 结构连接引导iTBS第2周HAM-D减分显著优于5-cm规则(LSMD=8.79个百分点)。
- 第6周结构连接和功能连接引导均显著优于5-cm规则,效应量分别为1.03和0.75。
- 第12周组间差异不再显著,不良事件三组相当,无癫痫或躁狂。
核心结论
- 结构连接引导iTBS相比5-cm靶向显示出初步的抑郁疗效改善证据,支持基于sgACC连接引导的精准神经调控。
研究设计与样本
- 单中心、随机、双盲、三臂试验,2023年2月至2025年3月纳入18-65岁重度抑郁或双相II型抑郁且至少一种抗抑郁药治疗失败的成人。
- 随机分配接受2周共20次iTBS,采用机器人神经导航,靶向策略为5-cm规则、功能连接引导或结构连接引导。
- 主要结局为第2周17项汉密尔顿抑郁量表(HAM-D)评分百分比减分。
主要发现
- 123例随机分配,119例纳入改良意向治疗分析(5-cm组40例,结构连接组39例,功能连接组40例)。
- 第2周结构连接引导iTBS的HAM-D减分显著优于5-cm规则(最小二乘均值差[LSMD]=8.79个百分点,95%CI=2.19,15.40;Cohen's d=0.70)。
- 第6周结构连接引导和功能连接引导均显著优于5-cm组(结构连接LSMD=12.87个百分点,95%CI=6.21,19.54;Cohen's d=1.03;功能连接LSMD=9.41个百分点,95%CI=2.84,15.98;Cohen's d=0.75)。
- 第12周组间差异不再显著。
- 不良事件三组相当,无癫痫或躁狂发生。
关键数值与推荐
- 主要结局为第2周HAM-D评分百分比减分。
- 次要结局包括第6周和第12周HAM-D减分、应答或缓解、自评症状、认知测验表现和不良事件。
临床怎么用
- 对于至少一种抗抑郁药治疗失败的重度抑郁或双相II型抑郁成人,结构连接引导iTBS可能在早期(第2周)和第6周提供优于5-cm规则的抗抑郁效果。
- 功能连接引导iTBS在第6周也显示优于5-cm规则的疗效,但第12周差异不显著,需结合临床实际选择靶向策略。
局限性
- 单中心设计可能限制结果的普遍性。
- 样本量较小(119例纳入分析),结论需更大规模试验验证。
- 第12周组间差异不再显著,长期疗效不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Scalp-based repetitive transcranial magnetic stimulation targeting the left dorsolateral prefrontal cortex (DLPFC) does not account for interindividual variability. This trial was designed to determine whether individualized connectivity-guided intermittent theta-burst stimulation (iTBS) improves antidepressant outcomes compared with 5-cm targeting. METHODS: In this single-center, randomized, double-blind, three-arm trial (February 2023-March 2025), adults ages 18-65 years with major depressive disorder or bipolar II depression (≥1 antidepressant failure) were randomly assigned to receive 20 sessions of iTBS over 2 weeks using robotic neuronavigation with one of three targeting strategies: 5-cm rule, functional connectivity (FC)-guided targeting showing negative resting-state connectivity with the subgenual anterior cingulate cortex (sgACC), or structural connectivity (SC)-guided sites defined by probabilistic tractography to the sgACC. The primary outcome was percentage reduction in 17-item Hamilton Depression Rating Scale (HAM-D) score at week 2. Secondary outcomes included HAM-D score reduction at weeks 6 and 12, response or remission, self-reported symptoms, performance on a cognitive battery, and adverse events. RESULTS: Of 123 randomized participants, 119 were included in the modified intention-to-treat analyses (5-cm, N=40; SC-guided, N=39; FC-guided, N=40). SC-guided iTBS produced significantly greater HAM-D score reduction than the 5-cm rule at week 2 (least squares mean difference [LSMD]=8.79 percentage points, 95% CI=2.19, 15.40; Cohen's d=0.70). At week 6, both SC-guided and FC-guided groups showed significantly greater improvement than the 5-cm group (SC-guided LSMD=12.87 percentage points, 95% CI=6.21, 19.54; Cohen's d=1.03; and FC-guided LSMD=9.41 percentage points, 95% CI=2.84, 15.98; Cohen's d=0.75). By week 12, between-group differences were no longer significant. Adverse events were comparable across groups, with no seizures or mania. CONCLUSIONS: SC-guided iTBS produced promising preliminary evidence of improved antidepressant response compared with 5-cm targeting, supporting sgACC-based connectivity-guided precision neuromodulation in depression.
引用
- Li M, Wu Z, Lu X, et al. Individualized Connectivity-Guided Versus Conventional Targeting of Accelerated Theta-Burst Stimulation in Depression: A Randomized, Double-Blind, Parallel-Design Trial. Am J Psychiatry. 2026. PMID: 42581396. doi:10.1176/appi.ajp.20251084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。